Arda Durmaz
Overview
Explore the profile of Arda Durmaz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
247
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guarnera L, Gurnari C, Bravo-Perez C, Durmaz A, Williams N, Awada H, et al.
Leukemia
. 2025 Jan;
39(3):748-751.
PMID: 39755843
No abstract available.
2.
Shultes P, Tadele D, Durmaz A, Weaver D, Barker-Clarke R, Dinh M, et al.
bioRxiv
. 2024 Dec;
PMID: 39677818
Cell-cell fusion has been implicated in various physiological and pathological processes, including cancer progression. This study investigated the role of cell-cell fusion in non-small cell lung cancer (NSCLC), focusing on...
3.
Kawashima N, Gurnari C, Bravo-Perez C, Kubota Y, Pagliuca S, Guarnera L, et al.
Leukemia
. 2024 Nov;
39(2):451-459.
PMID: 39572711
Past studies described occasional patients with myeloid neoplasms (MN) and coexistent large granular lymphocytic leukemia (LGLL) or T-cell clonopathy of unknown significance (TCUS), which may represent expansion of myeloid clonal...
4.
Kawashima N, Kubota Y, Bravo-Perez C, Guarnera L, Williams N, Durmaz A, et al.
J Hematol Oncol
. 2024 Sep;
17(1):87.
PMID: 39334207
DNA methyltransferase 3 A mutations (DNMT3A) are frequent in myeloid neoplasia (MN) and mostly heterozygous. However, cases with multiple DNMT3A can be also encountered but their clinical and genetic landscape...
5.
Awada H, Durmaz A, Kewan T, Ullah F, Dima D, Awada H, et al.
Leukemia
. 2024 May;
38(6):1411-1414.
PMID: 38734787
No abstract available.
6.
Awada H, Gurnari C, Visconte V, Durmaz A, Kuzmanovic T, Awada H, et al.
Leukemia
. 2024 Apr;
38(6):1266-1274.
PMID: 38684821
Therapy-related myeloid neoplasms (tMN) are complications of cytotoxic therapies. Risk of tMN is high in recipients of autologous hematopoietic stem cell transplantation (aHSCT). Acquisition of genomic mutations represents a key...
7.
Durmaz A, Visconte V
Elife
. 2024 Mar;
13.
PMID: 38427029
A new mathematical model that can be applied to both single-cell and bulk DNA sequencing data sheds light on the processes governing population dynamics in stem cells.
8.
Kubota Y, Gu X, Terkawi L, Bodo J, Przychodzen B, Awada H, et al.
Nat Commun
. 2024 Feb;
15(1):1832.
PMID: 38418452
PHF6 mutations (PHF6) are identified in various myeloid neoplasms (MN). However, little is known about the precise function and consequences of PHF6 in MN. Here we show three main findings...
9.
Kewan T, Durmaz A, Bahaj W, Gurnari C, Terkawi L, Awada H, et al.
Nat Commun
. 2024 Feb;
15(1):1184.
PMID: 38332139
No abstract available.
10.
Zhang Z, Wang C, Zhao Z, Yi Z, Durmaz A, Yu J, et al.
Pac Symp Biocomput
. 2023 Dec;
29:521-533.
PMID: 38160304
Advances in molecular characterization have reshaped our understanding of low-grade glioma (LGG) subtypes, emphasizing the need for comprehensive classification beyond histology. Lever-aging this, we present a novel approach, network-based Subnetwork...